logo

HALEOSLABS vs WANBURY: Stock Comparison

HALEOS LABS vs WANBURYUpdated 22 Oct 26, 4:08 PM ISTNSE & company filings

WANBURY is the larger company by market capitalisation. HALEOS LABS shows a higher dividend yield, faster revenue growth and lower leverage, while WANBURY shows a lower P/E, a higher ROE and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

HALEOSLABS leads 4; WANBURY leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

HALEOSLABSWANBURY

Valuation lens

What price are you paying?

Market CapContext only
₹490 Cr
₹651 Cr
P/E RatioWANBURY has the lower reading
29.35x
0x ✓
P/B RatioWANBURY has the lower reading
2.17x
0x ✓
EPSHALEOSLABS has the higher reading
₹8.75 ✓
₹4.1
Book ValueContext only
₹759.29
₹43.94
Dividend YieldHALEOSLABS has the higher reading
0.09% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
WANBURY is the larger company
₹651 Cr vs ₹490 Cr
P/E Ratio
WANBURY has a lower P/E
0x vs 29.35x
P/B Ratio
WANBURY has a lower P/B
0x vs 2.17x
EPS
HALEOSLABS has higher earnings per share
₹8.75 vs ₹4.1
Dividend Yield
HALEOSLABS has a higher dividend yield
0.09% vs 0%
Revenue Growth (TTM YoY)
HALEOSLABS has faster revenue growth
0% vs -19.2%
ROE
WANBURY has a higher ROE
45.78% vs 7.75%
ROCE
WANBURY has a higher ROCE
25.06% vs 6.63%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricHALEOSLABSWANBURY
Sector—Healthcare
Industry—Pharmaceuticals

Price

MetricHALEOSLABSWANBURY
Live Price₹1,611.3₹185.77
Day Change1.74%-1.01%
Volume8951.29 L
52-Week High₹1,774₹358.85
52-Week Low₹1,181₹161.5
Distance from 52W High-9.17%-48.23%

Valuation

MetricHALEOSLABSWANBURY
Market Cap₹490 Cr₹651 Cr
P/E Ratio29.35x0x
P/B Ratio2.17x0x
EPS₹8.75₹4.1
Book Value₹759.29₹43.94
Dividend Yield0.09%0%

Growth

MetricHALEOSLABSWANBURY
Revenue Growth (TTM YoY)0%-19.2%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricHALEOSLABSWANBURY
ROE7.75%45.78%
ROCE6.63%25.06%
Net Margin5.33%10.17%
Operating Margin9.48%13.81%
Debt to Equity0.47x1.49x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricHALEOSLABSWANBURY
Promoter Holding72.11%34.36%
FII Holding0%0.89%▲ 0.3 pp
DII Holding0.31%0.06%▲ 0.06 pp
Public Holding27.58%56.03%▼ 0.36 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: HALEOS LABS and WANBURY.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.